Overall, these data indicate the essential role of ADAR2 editing in glioblastoma, acting on multiple targets (CDC14B, pri-miR-221/222, pri-miR-21, miR-376a-5p, GRIA2) that together contribute to varying extents to cancer progression. This evidence concerns the gene GRIA2 and glioblastoma.